참고문헌 (51)

1. 1 Bernal W Auzinger G Dhawan A Wendon J Acute liver failure Lancet 376 190 201 2010 10.1016/S0140-6736(10)60274-7 20638564 

   상세보기

2. 2 Hinson JA Roberts DW James LP Mechanisms of acetaminophen-induced liver necrosis Handb Exp Pharmacol 369 405 2010 10.1007/978-3-642-00663-0_12 2836803 --> 20020268 

   상세보기

3. 3 James LP Alonso EM Hynan LS Hinson JA Davern TJ Lee WM Squires RH Pediatric Acute Liver Failure Study Group Detection of acetaminophen protein adducts in children with acute liver failure of indeterminate cause Pediatrics 118 e676 e681 2006 10.1542/peds.2006-0069 16950959 

   상세보기

4. 4 Burcham PC Harman AW Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes J Biol Chem 266 5049 5054 1991 2002047 

5. 5 Adams J The proteasome: structure, function, and role in the cell Cancer Treat Rev 29 Suppl 1 3 9 2003 10.1016/S0305-7372(03)00081-1 12738238 

   상세보기

6. 6 Richardson PG Mitsiades C Hideshima T Anderson KC Bortezomib: proteasome inhibition as an effective anticancer therapy Annu Rev Med 57 33 47 2006 10.1146/annurev.med.57.042905.122625 16409135 

   상세보기

7. 7 Deming DA Ninan J Bailey HH Kolesar JM Eickhoff J Reid JM Ames MM McGovern RM Alberti D Marnocha R A Phase I study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors Invest New Drugs 32 323 329 2014 10.1007/s10637-013-0035-8 3949160 --> 24114123 

   상세보기

8. 8 Blouin JM Duchartre Y Costet P Lalanne M Ged C Lain A Millet O de Verneuil H Richard E Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria Proc Natl Acad Sci USA 110 18238 18243 2013 10.1073/pnas.1314177110 3831495 --> 24145442 

   상세보기

9. 9 Li Z Wu Q Yan Z Li D Lu G Mou W Wu S Pan X Lu Q Xu K The protection and therapy effects of bortezomib in murine acute graft-versus-host disease Transplant Proc 45 2527 2535 2013 10.1016/j.transproceed.2013.03.042 23953575 

   상세보기

10. 10 Park WJ Park JW Erez-Roman R Kogot-Levin A Bame JR Tirosh B Saada A Merrill AH Jr Pewzner-Jung Y Futerman AH Protection of a ceramide synthase 2 null mouse from drug-induced liver injury: role of gap junction dysfunction and connexin 32 mislocalization J Biol Chem 288 30904 30916 2013 10.1074/jbc.M112.448852 3829405 --> 24019516 

    상세보기

11. 11 Wagner-Ballon O Pisani DF Gastinne T Tulliez M Chaligné R Lacout C Auradé F Villeval JL Gonin P Vainchenker W Giraudier S Proteasome inhibitor bortezomib impairs both myelofibrosis and osteosclerosis induced by high thrombopoietin levels in mice Blood 110 345 353 2007 10.1182/blood-2006-10-054502 17374740 

    상세보기

12. 12 Carvalho AN Marques C Rodrigues E Henderson CJ Wolf CR Pereira P Gama MJ Ubiquitin-proteasome system impairment and MPTP-induced oxidative stress in the brain of C57BL/6 wild-type and GSTP knockout mice Mol Neurobiol 47 662 672 2013 10.1007/s12035-012-8368-4 23129554 

    상세보기

13. 13 Sun H Kosaras B Klein PM Jensen FE Mammalian target of rapamycin complex 1 activation negatively regulates Polo-like kinase 2-mediated homeostatic compensation following neonatal seizures Proc Natl Acad Sci USA 110 5199 5204 2013 10.1073/pnas.1208010110 3612683 --> 23479645 

    상세보기

14. 14 Oerlemans R Franke NE Assaraf YG Cloos J van Zantwijk I Berkers CR Scheffer GL Debipersad K Vojtekova K Lemos C Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein Blood 112 2489 2499 2008 10.1182/blood-2007-08-104950 18565852 

    상세보기

15. 15 Markovina S Callander NS O'Connor SL Kim J Werndli JE Raschko M Leith CP Kahl BS Kim K Miyamoto S Bortezomib-resistant nuclear factor-kappaB activity in multiple myeloma cells Mol Cancer Res 6 1356 1364 2008 10.1158/1541-7786.MCR-08-0108 2587345 --> 18708367 

    상세보기

16. 16 Park JW Park ES Choi EN Park HY Jung SC Altered brain gene expression profiles associated with the pathogenesis of phenylketonuria in a mouse model Clin Chim Acta 401 90 99 2009 10.1016/j.cca.2008.11.019 19073163 

    상세보기

17. 17 Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method Methods 25 402 408 2001 10.1006/meth.2001.1262 11846609 

    상세보기

18. 18 Phillips IR Shephard EA Cytochrome P450 Protocols Humana Press Totowa, NJ 2006 

19. 19 Reinke LA Moyer MJ p-Nitrophenol hydroxylation. A microsomal oxidation which is highly inducible by ethanol Drug Metab Dispos 13 548 552 1985 2865101 

    상세보기

20. 20 Matsunaga N Ikeda M Takiguchi T Koyanagi S Ohdo S The molecular mechanism regulating 24-hour rhythm of CYP2E1 expression in the mouse liver Hepatology 48 240 251 2008 10.1002/hep.22304 18537186 

    상세보기

21. 21 Park JW Lee MH Choi JO Park HY Jung SC Tissue-specific activation of mitogen-activated protein kinases for expression of transthyretin by phenylalanine and its metabolite, phenylpyruvic acid Exp Mol Med 42 105 115 2010 10.3858/emm.2010.42.2.012 2827827 --> 19946178 

    상세보기

22. 22 Wong FW Chan WY Lee SS Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression Toxicol Appl Pharmacol 153 109 118 1998 10.1006/taap.1998.8547 9875305 

    상세보기

23. 23 Kang JS Wanibuchi H Morimura K Wongpoomchai R Chusiri Y Gonzalez FJ Fukushima S Role of CYP2E1 in thioacetamide-induced mouse hepatotoxicity Toxicol Appl Pharmacol 228 295 300 2008 10.1016/j.taap.2007.11.010 18374380 

    상세보기

24. 24 Lee SS Buters JT Pineau T Fernandez-Salguero P Gonzalez FJ Role of CYP2E1 in the hepatotoxicity of acetaminophen J Biol Chem 271 12063 12067 1996 10.1074/jbc.271.20.12063 8662637 

    상세보기

25. 25 Patel SJ Milwid JM King KR Bohr S Iracheta-Vellve A Li M Vitalo A Parekkadan B Jindal R Yarmush ML Gap junction inhibition prevents drug-induced liver toxicity and fulminant hepatic failure Nat Biotechnol 30 179 183 2012 10.1038/nbt.2089 3609650 --> 22252509 

    상세보기

26. 26 Ueno T Gonzalez FJ Transcriptional control of the rat hepatic CYP2E1 gene Mol Cell Biol 10 4495 4505 1990 10.1128/MCB.10.9.4495 361036 --> 2388615 

    상세보기

27. 27 Liu SY Gonzalez FJ Role of the liver-enriched transcription factor HNF-1 alpha in expression of the CYP2E1 gene DNA Cell Biol 14 285 293 1995 10.1089/dna.1995.14.285 7710685 

    상세보기

28. 28 Cheung C Akiyama TE Kudo G Gonzalez FJ Hepatic expression of cytochrome P450s in hepatocyte nuclear factor 1-alpha (HNF1alpha)-deficient mice Biochem Pharmacol 66 2011 2020 2003 10.1016/S0006-2952(03)00586-0 14599559 

    상세보기

29. 29 Nawrocki ST Carew JS Dunner K Jr Boise LH Chiao PJ Huang P Abbruzzese JL McConkey DJ Bortezomib inhibits PKR-like endoplasmic reticulum (ER) kinase and induces apoptosis via ER stress in human pancreatic cancer cells Cancer Res 65 11510 11519 2005 10.1158/0008-5472.CAN-05-2394 16357160 

    상세보기

30. 30 Armstrong JL Flockhart R Veal GJ Lovat PE Redfern CP Regulation of endoplasmic reticulum stress-induced cell death by ATF4 in neuroectodermal tumor cells J Biol Chem 285 6091 6100 2010 10.1074/jbc.M109.014092 2825403 --> 20022965 

    상세보기

31. 31 Hur KY So JS Ruda V Frank-Kamenetsky M Fitzgerald K Koteliansky V Iwawaki T Glimcher LH Lee AH IRE1α activation protects mice against acetaminophen-induced hepatotoxicity J Exp Med 209 307 318 2012 10.1084/jem.20111298 3280871 --> 22291093 

    상세보기

32. 32 Lee AS The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress Methods 35 373 381 2005 10.1016/j.ymeth.2004.10.010 15804610 

    상세보기

33. 33 Oyadomari S Mori M Roles of CHOP/GADD153 in endoplasmic reticulum stress Cell Death Differ 11 381 389 2004 10.1038/sj.cdd.4401373 14685163 

    상세보기

34. 34 Basseri S Lhoták S Sharma AM Austin RC The chemical chaperone 4-phenylbutyrate inhibits adipogenesis by modulating the unfolded protein response J Lipid Res 50 2486 2501 2009 10.1194/jlr.M900216-JLR200 2781320 --> 19461119 

    상세보기

35. 35 Tong X Dong S Yu M Wang Q Tao L Role of heteromeric gap junctions in the cytotoxicity of cisplatin Toxicology 310 53 60 2013 10.1016/j.tox.2013.05.010 23747833 

    상세보기

36. 36 Asamoto M Hokaiwado N Murasaki T Shirai T Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals Hepatology 40 205 210 2004 10.1002/hep.20256 15239104 

    상세보기

37. 37 Herrmann J Ciechanover A Lerman LO Lerman A The ubiquitin-proteasome system in cardiovascular diseases - a hypothesis extended Cardiovasc Res 61 11 21 2004 10.1016/j.cardiores.2003.09.033 14732197 

    상세보기

38. 38 Mani A Gelmann EP The ubiquitin-proteasome pathway and its role in cancer J Clin Oncol 23 4776 4789 2005 10.1200/JCO.2005.05.081 16034054 

    상세보기

39. 39 Ciechanover A Brundin P The ubiquitin proteasome system in neurodegenerative diseases: sometimes the chicken, sometimes the egg Neuron 40 427 446 2003 10.1016/S0896-6273(03)00606-8 14556719 

    상세보기

40. 40 Goasduff T Cederbaum AI NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species Arch Biochem Biophys 370 258 270 1999 10.1006/abbi.1999.1399 10510285 

    상세보기

41. 41 Roberts BJ Evidence of proteasome-mediated cytochrome P-450 degradation J Biol Chem 272 9771 9778 1997 9092510 

    상세보기

42. 42 Park HS Jun Y Han CR Woo HJ Kim YH Proteasome inhibitor MG132-induced apoptosis via ER stress-mediated apoptotic pathway and its potentiation by protein tyrosine kinase p56lck in human Jurkat T cells Biochem Pharmacol 82 1110 1125 2011 10.1016/j.bcp.2011.07.085 21819973 

    상세보기

43. 43 Levêque D Carvalho MC Maloisel F Review. Clinical pharmacokinetics of bortezomib In Vivo 21 273 278 2007 17436576 

44. 44 Pérez MJ Cederbaum AI Proteasome inhibition potentiates CYP2E1-mediated toxicity in HepG2 cells Hepatology 37 1395 1404 2003 10.1053/jhep.2003.50228 12774019 

    상세보기

45. 45 Fernandes R Girão H Pereira P High glucose down-regulates intercellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism J Biol Chem 279 27219 27224 2004 10.1074/jbc.M400446200 15123628 

    상세보기

46. 46 Minogue PJ Beyer EC Berthoud VM A connexin50 mutant, CX50fs, that causes cataracts is unstable, but is rescued by a proteasomal inhibitor J Biol Chem 288 20427 20434 2013 10.1074/jbc.M113.452847 3711308 --> 23720739 

    상세보기

47. 47 Laing JG Tadros PN Westphale EM Beyer EC Degradation of connexin43 gap junctions involves both the proteasome and the lysosome Exp Cell Res 236 482 492 1997 10.1006/excr.1997.3747 9367633 

    상세보기

48. 48 Huang T Wan Y Zhu Y Fang X Hiramatsu N Hayakawa K Paton AW Paton JC Kitamura M Yao J Downregulation of gap junction expression and function by endoplasmic reticulum stress J Cell Biochem 107 973 983 2009 10.1002/jcb.22202 19492336 

    상세보기

49. 49 Larson AM Acetaminophen hepatotoxicity Clin Liver Dis 11 525 548 vi 2007 10.1016/j.cld.2007.06.006 17723918 

    상세보기

50. 50 Farfel-Becker T Vitner E Dekel H Leshem N Enquist IB Karlsson S Futerman AH No evidence for activation of the unfolded protein response in neuronopathic models of Gaucher disease Hum Mol Genet 18 1482 1488 2009 10.1093/hmg/ddp061 19193629 

    상세보기

51. 51 Hetz C Lee AH Gonzalez-Romero D Thielen P Castilla J Soto C Glimcher LH Unfolded protein response transcription factor XBP-1 does not influence prion replication or pathogenesis Proc Natl Acad Sci USA 105 757 762 2008 10.1073/pnas.0711094105 2206609 --> 18178615 

    상세보기